CHADDS FORD, Pa.–MOBILion Systems, Inc., a life science company developing an advanced analytical instrument platform that efficiently identifies the most challenging molecules to accelerate biologic drug development and improve diagnostic insights, today announced they raised $15.4 million in Series A financing. The round was led by Agilent Technologies, with participation from IP Group Inc., Hostplus, […]

Hitachi High-Technologies Corporation (TSE:8036/Hitachi High-Tech) have undertaken a third-party allotment of shares (this capital alliance) with Vironova AB (Main office: Stockholm, Sweden /CEO: Mohammed Homman/Vironova), who develop and sell analysis software for transmission electron microscopes (TEM) along with carrying out contract analysis for pharmaceutical companies. Through this capital alliance, we aim to jointly develop TEM […]

BOSTON — TetraScience, developers of the industry’s first cloud-based data integration platform for life sciences R&D, today announced it has secured a strategic investment from Waters Corporation (NYSE: WAT), the world’s leading specialty measurement company. Waters Corporation joins a roster of leading venture investors in TetraScience’s $8M series A round of financing including Floodgate Capital, First Round Capital, Underscore […]

LexaGene Announces Closing of CAD$6.64 Million Financing BEVERLY, Mass – (October 29, 2019) –  LexaGene Holdings Inc. (TSX VENTURE: LXG) (OTCQB: LXXGF) (“LexaGene” or the “Company“) is pleased to announce that it has closed its previously announced offering of units (the “Units”) for aggregate gross proceeds of CAD$6.64 million (the “Offering”). The Company issued 12,769,626 Units at a price […]

Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst Capital, RTI International, and Inova Health Systems ST. LOUIS–PierianDx, the leading clinical genomics informatics company, today announced that it has closed a $27 million Series B funding round led by ATW Partners and SJF Ventures that also includes existing investors Health […]

IsoPlexis continues to build its pipeline of revolutionary, single-cell, proteomic biology solutions with novel, tumor cell, proteomic signaling pathway technology BRANFORD, Conn. — IsoPlexis, the leading life sciences company in the single-cell proteomics space, announced today that it has received $2 million in grant funding from the National Cancer Institute’s Small Business Innovation Research (NCI SBIR) Development Center for […]

SAN DIEGO — BIONANO GENOMICS, INC. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today announced the pricing of an underwritten public offering of 20,937,558 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) […]

Fluorescent Dye Platform Will Enable New Breadth and Depth in Single Cell Analysis DURHAM, N.C. — Phitonex, Inc., developers of next generation fluorescent labels for biomarker detection on single cells, announces that is has closed a $2M seed round led by private investors. In life science research and diagnostics, the number of questions per individual cell is the […]

The study, done in collaboration with the Fred Hutchinson Cancer Research Center, will leverage the Mission Bio Tapestri® Platform to improve the measurement of residual cancerous cells remaining post-treatment   SOUTH SAN FRANCISCO, Calif. Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced that it has been awarded a […]

Gardner, MA: New England Peptide, a leading provider of high-quality custom peptides and antibodies to the global life sciences market, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support the company’s worldwide growth initiatives, including fueling the expansion of peptide synthesis capabilities to better serve an […]